BioCryst Pharmaceuticals (European ORLADEYO Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

BioCryst Pharmaceuticals (European ORLADEYO Business) General Information

Description

A portfolio of medicine located in the United States. The portfolio comprises medicines for adults and children 12 years of age and older to prevent attacks of hereditary angioedema (HAE).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Ireland
Primary Industry
Buildings and Property
Corporate Office
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCryst Pharmaceuticals (European ORLADEYO Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioCryst Pharmaceuticals (European ORLADEYO Business)‘s full profile, request access.

Request a free trial

BioCryst Pharmaceuticals (European ORLADEYO Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioCryst Pharmaceuticals (European ORLADEYO Business)‘s full profile, request access.

Request a free trial

BioCryst Pharmaceuticals (European ORLADEYO Business) FAQs

  • Where is BioCryst Pharmaceuticals (European ORLADEYO Business) headquartered?

    BioCryst Pharmaceuticals (European ORLADEYO Business) is headquartered in Ireland.

  • What industry is BioCryst Pharmaceuticals (European ORLADEYO Business) in?

    BioCryst Pharmaceuticals (European ORLADEYO Business)’s primary industry is Buildings and Property.

  • Is BioCryst Pharmaceuticals (European ORLADEYO Business) a private or public company?

    BioCryst Pharmaceuticals (European ORLADEYO Business) is a Private company.

  • What is the current valuation of BioCryst Pharmaceuticals (European ORLADEYO Business)?

    The current valuation of BioCryst Pharmaceuticals (European ORLADEYO Business) is .

  • What is BioCryst Pharmaceuticals (European ORLADEYO Business)’s current revenue?

    The current revenue for BioCryst Pharmaceuticals (European ORLADEYO Business) is .

  • Who are BioCryst Pharmaceuticals (European ORLADEYO Business)’s investors?

    BioCryst Pharmaceuticals has invested in BioCryst Pharmaceuticals (European ORLADEYO Business).

  • When was BioCryst Pharmaceuticals (European ORLADEYO Business) acquired?

    BioCryst Pharmaceuticals (European ORLADEYO Business) was acquired on 01-Oct-2025.

  • Who acquired BioCryst Pharmaceuticals (European ORLADEYO Business)?

    BioCryst Pharmaceuticals (European ORLADEYO Business) was acquired by Neopharmed Gentili.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process